跳轉至內容
Merck
全部照片(2)

重要文件

855810P

Avanti

26:0 溶血 PC

1-hexacosanoyl-2-hydroxy-sn-glycero-3-phosphocholine, powder

同義詞:

1-十六烷酰基-sn-甘油-3-磷酸胆碱;PC(26:0/0:0)

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C34H70NO7P
CAS號碼:
分子量::
635.90
MDL號碼:
分類程式碼代碼:
51191904
NACRES:
NA.25

化驗

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

形狀

powder

包裝

pkg of 1 × 10 mg (855810P-10mg)
pkg of 1 × 25 mg (855810P-25mg)
pkg of 1 × 5 mg (855810P-5mg)

製造商/商標名

Avanti Research - A Croda Brand 855810P

運輸包裝

dry ice

儲存溫度

−20°C

一般說明

溶血磷脂酰胆碱(LPC)是一种具有生物活性的促炎脂质,其极性头部含有胆碱基团。它是由病理反应产生的。

應用

26:0 Lyso PC可用作提取C26:0-溶血磷脂酰胆碱(LPC)的内标。

生化/生理作用

溶血磷脂酰胆碱(LPC)诱导许多第二信使,包括蛋白激酶C、细胞外信号调节激酶和蛋白酪氨酸激酶。它可改变不同类型细胞的各种生物学功能,包括内皮细胞、平滑肌细胞、单核细胞、巨噬细胞和T细胞。LPC与动脉粥样硬化和炎性疾病有关。

包裝

5 mL棕色玻璃螺旋盖样品瓶(855810P-10mg)
5 mL棕色玻璃螺旋盖样品瓶(855810P-25mg)
5 mL棕色玻璃螺旋盖样品瓶(855810P-5mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

儲存類別代碼

11 - Combustible Solids


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Xinying Hong et al.
Genetics in medicine : official journal of the American College of Medical Genetics (2020-04-21)
To develop a multiplexed assay for the newborn screening of lysosomal storage disorders and additional inborn errors in a flexible, comprehensive, and affordable manner to keep up with the expansion of the newborn screening panel. Ultraperformance liquid chromatography-tandem mass spectrometry
A thyroid hormone-based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy
Hartley MD, et al.
Endocrinology, 158(5), 1328-1338 (2017)
Analysis of phospholipid species in rat peritoneal surface layer by liquid chromatography/electrospray ionization ion-trap mass spectrometry
Gao F, et al.
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1761(7), 667-676 (2006)
Kelsey B Law et al.
Autophagy, 13(5), 868-884 (2017-05-20)
Peroxisome biogenesis disorders (PBDs) are metabolic disorders caused by the loss of peroxisomes. The majority of PBDs result from mutation in one of 3 genes that encode for the peroxisomal AAA ATPase complex (AAA-complex) required for cycling PEX5 for peroxisomal
Role of lysophosphatidylcholine (LPC) in atherosclerosis
Matsumoto T, et al.
Current Medicinal Chemistry, 14(30), 3209-3220 (2007)

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務